nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—GNRHR—brainstem—alcohol dependence	0.0237	0.21	CbGeAlD
Nafarelin—GNRHR—Peptide GPCRs—OPRK1—alcohol dependence	0.0225	0.091	CbGpPWpGaD
Nafarelin—Vaginal dryness—Citalopram—alcohol dependence	0.0221	0.0345	CcSEcCtD
Nafarelin—Prolonged menses—Citalopram—alcohol dependence	0.0183	0.0286	CcSEcCtD
Nafarelin—GNRHR—gonad—alcohol dependence	0.0175	0.156	CbGeAlD
Nafarelin—Vulvovaginal dryness—Citalopram—alcohol dependence	0.0169	0.0264	CcSEcCtD
Nafarelin—Neurosis—Acamprosate—alcohol dependence	0.0162	0.0253	CcSEcCtD
Nafarelin—GNRHR—Peptide GPCRs—OPRD1—alcohol dependence	0.0151	0.0611	CbGpPWpGaD
Nafarelin—Ascites—Acamprosate—alcohol dependence	0.0141	0.022	CcSEcCtD
Nafarelin—GNRHR—endocrine gland—alcohol dependence	0.0133	0.118	CbGeAlD
Nafarelin—Skin odour abnormal—Citalopram—alcohol dependence	0.013	0.0204	CcSEcCtD
Nafarelin—GNRHR—testis—alcohol dependence	0.0126	0.112	CbGeAlD
Nafarelin—GNRHR—nervous system—alcohol dependence	0.0124	0.11	CbGeAlD
Nafarelin—GNRHR—central nervous system—alcohol dependence	0.0119	0.106	CbGeAlD
Nafarelin—GNRHR—cerebellum—alcohol dependence	0.0117	0.104	CbGeAlD
Nafarelin—GNRHR—Peptide GPCRs—OPRM1—alcohol dependence	0.0116	0.047	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—CHRM2—alcohol dependence	0.0108	0.0434	CbGpPWpGaD
Nafarelin—Libido increased—Acamprosate—alcohol dependence	0.0105	0.0164	CcSEcCtD
Nafarelin—Eye pain—Disulfiram—alcohol dependence	0.0104	0.0163	CcSEcCtD
Nafarelin—Deep vein thrombosis—Naltrexone—alcohol dependence	0.00993	0.0155	CcSEcCtD
Nafarelin—Neurosis—Citalopram—alcohol dependence	0.00969	0.0151	CcSEcCtD
Nafarelin—GNRHR—brain—alcohol dependence	0.00948	0.0842	CbGeAlD
Nafarelin—Seborrhoeic dermatitis—Naltrexone—alcohol dependence	0.00886	0.0139	CcSEcCtD
Nafarelin—Menorrhagia—Acamprosate—alcohol dependence	0.00863	0.0135	CcSEcCtD
Nafarelin—Loss of libido—Citalopram—alcohol dependence	0.00829	0.013	CcSEcCtD
Nafarelin—GNRHR—GPCRs, Other—DRD4—alcohol dependence	0.00766	0.0309	CbGpPWpGaD
Nafarelin—Transient ischaemic attack—Citalopram—alcohol dependence	0.00759	0.0119	CcSEcCtD
Nafarelin—GNRHR—GPCRs, Other—CNR1—alcohol dependence	0.00731	0.0295	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—HTR7—alcohol dependence	0.00714	0.0288	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.0071	0.0287	CbGpPWpGaD
Nafarelin—Pulmonary embolism—Acamprosate—alcohol dependence	0.00639	0.00998	CcSEcCtD
Nafarelin—Deep vein thrombosis—Citalopram—alcohol dependence	0.00629	0.00984	CcSEcCtD
Nafarelin—Vaginal discharge—Citalopram—alcohol dependence	0.00629	0.00984	CcSEcCtD
Nafarelin—Libido increased—Citalopram—alcohol dependence	0.00629	0.00984	CcSEcCtD
Nafarelin—Urinary incontinence—Acamprosate—alcohol dependence	0.00617	0.00964	CcSEcCtD
Nafarelin—Pulmonary embolism—Naltrexone—alcohol dependence	0.00604	0.00945	CcSEcCtD
Nafarelin—Breast enlargement—Citalopram—alcohol dependence	0.0059	0.00923	CcSEcCtD
Nafarelin—Rash maculo-papular—Acamprosate—alcohol dependence	0.0058	0.00907	CcSEcCtD
Nafarelin—Menstrual disorder—Citalopram—alcohol dependence	0.00562	0.00878	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—OPRK1—alcohol dependence	0.00541	0.0218	CbGpPWpGaD
Nafarelin—Vaginal haemorrhage—Citalopram—alcohol dependence	0.00517	0.00809	CcSEcCtD
Nafarelin—Menorrhagia—Citalopram—alcohol dependence	0.00517	0.00809	CcSEcCtD
Nafarelin—Libido decreased—Acamprosate—alcohol dependence	0.005	0.00781	CcSEcCtD
Nafarelin—GNRHR—GPCRs, Other—HTR2A—alcohol dependence	0.005	0.0202	CbGpPWpGaD
Nafarelin—Increased appetite—Acamprosate—alcohol dependence	0.00493	0.00771	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00478	0.0193	CbGpPWpGaD
Nafarelin—Libido decreased—Naltrexone—alcohol dependence	0.00473	0.00739	CcSEcCtD
Nafarelin—Hot flush—Naltrexone—alcohol dependence	0.00469	0.00733	CcSEcCtD
Nafarelin—Increased appetite—Naltrexone—alcohol dependence	0.00467	0.0073	CcSEcCtD
Nafarelin—Menopausal symptoms—Naltrexone—alcohol dependence	0.00465	0.00727	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.0046	0.00719	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00458	0.0185	CbGpPWpGaD
Nafarelin—Acne—Citalopram—alcohol dependence	0.00455	0.00711	CcSEcCtD
Nafarelin—Breast pain—Citalopram—alcohol dependence	0.00439	0.00686	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.00435	0.0068	CcSEcCtD
Nafarelin—Dry skin—Acamprosate—alcohol dependence	0.00425	0.00664	CcSEcCtD
Nafarelin—Herpes simplex—Citalopram—alcohol dependence	0.00415	0.00649	CcSEcCtD
Nafarelin—Oliguria—Citalopram—alcohol dependence	0.00415	0.00649	CcSEcCtD
Nafarelin—Paraesthesia—Disulfiram—alcohol dependence	0.00415	0.00649	CcSEcCtD
Nafarelin—Gastritis—Acamprosate—alcohol dependence	0.0041	0.00641	CcSEcCtD
Nafarelin—Abdominal distension—Acamprosate—alcohol dependence	0.00403	0.0063	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.004	0.0162	CbGpPWpGaD
Nafarelin—Coordination abnormal—Citalopram—alcohol dependence	0.0039	0.00609	CcSEcCtD
Nafarelin—Pulmonary embolism—Citalopram—alcohol dependence	0.00383	0.00598	CcSEcCtD
Nafarelin—Cystitis noninfective—Citalopram—alcohol dependence	0.00374	0.00585	CcSEcCtD
Nafarelin—Urinary incontinence—Citalopram—alcohol dependence	0.0037	0.00578	CcSEcCtD
Nafarelin—Cystitis—Citalopram—alcohol dependence	0.0037	0.00578	CcSEcCtD
Nafarelin—Sweating increased—Naltrexone—alcohol dependence	0.00369	0.00577	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00367	0.0148	CbGpPWpGaD
Nafarelin—Weight increased—Acamprosate—alcohol dependence	0.00365	0.0057	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—OPRD1—alcohol dependence	0.00364	0.0147	CbGpPWpGaD
Nafarelin—Weight decreased—Acamprosate—alcohol dependence	0.00362	0.00567	CcSEcCtD
Nafarelin—Depression—Acamprosate—alcohol dependence	0.00356	0.00557	CcSEcCtD
Nafarelin—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00352	0.0055	CcSEcCtD
Nafarelin—Myocardial infarction—Acamprosate—alcohol dependence	0.0035	0.00547	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—PDYN—alcohol dependence	0.00349	0.0141	CbGpPWpGaD
Nafarelin—Rash maculo-papular—Citalopram—alcohol dependence	0.00348	0.00544	CcSEcCtD
Nafarelin—Neoplasm—Citalopram—alcohol dependence	0.00346	0.00541	CcSEcCtD
Nafarelin—Bladder pain—Citalopram—alcohol dependence	0.00346	0.00541	CcSEcCtD
Nafarelin—Weight increased—Naltrexone—alcohol dependence	0.00345	0.00539	CcSEcCtD
Nafarelin—Weight decreased—Naltrexone—alcohol dependence	0.00343	0.00536	CcSEcCtD
Nafarelin—Gynaecomastia—Citalopram—alcohol dependence	0.00343	0.00535	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.00338	0.0137	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—AVP—alcohol dependence	0.00338	0.0136	CbGpPWpGaD
Nafarelin—Depression—Naltrexone—alcohol dependence	0.00337	0.00527	CcSEcCtD
Nafarelin—Epistaxis—Acamprosate—alcohol dependence	0.00337	0.00527	CcSEcCtD
Nafarelin—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00333	0.00521	CcSEcCtD
Nafarelin—Asthenia—Disulfiram—alcohol dependence	0.00332	0.00519	CcSEcCtD
Nafarelin—Myocardial infarction—Naltrexone—alcohol dependence	0.00331	0.00518	CcSEcCtD
Nafarelin—Conjunctivitis—Naltrexone—alcohol dependence	0.00329	0.00514	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00326	0.0132	CbGpPWpGaD
Nafarelin—Ear pain—Citalopram—alcohol dependence	0.00326	0.00509	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CRHR1—alcohol dependence	0.00324	0.0131	CbGpPWpGaD
Nafarelin—Rhinitis—Acamprosate—alcohol dependence	0.00322	0.00503	CcSEcCtD
Nafarelin—Epistaxis—Naltrexone—alcohol dependence	0.00319	0.00498	CcSEcCtD
Nafarelin—Sinusitis—Naltrexone—alcohol dependence	0.00317	0.00496	CcSEcCtD
Nafarelin—Eye pain—Citalopram—alcohol dependence	0.00308	0.00481	CcSEcCtD
Nafarelin—Dizziness—Disulfiram—alcohol dependence	0.00306	0.00478	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—OPRK1—alcohol dependence	0.00306	0.0123	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CHRM2—alcohol dependence	0.00305	0.0123	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.00302	0.0122	CbGpPWpGaD
Nafarelin—Libido decreased—Citalopram—alcohol dependence	0.003	0.00468	CcSEcCtD
Nafarelin—Hot flush—Citalopram—alcohol dependence	0.00297	0.00464	CcSEcCtD
Nafarelin—Increased appetite—Citalopram—alcohol dependence	0.00296	0.00462	CcSEcCtD
Nafarelin—Menopausal symptoms—Citalopram—alcohol dependence	0.00295	0.0046	CcSEcCtD
Nafarelin—Rash—Disulfiram—alcohol dependence	0.00292	0.00456	CcSEcCtD
Nafarelin—Headache—Disulfiram—alcohol dependence	0.0029	0.00453	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.00285	0.0115	CbGpPWpGaD
Nafarelin—Cerebrovascular accident—Citalopram—alcohol dependence	0.00284	0.00443	CcSEcCtD
Nafarelin—Alopecia—Acamprosate—alcohol dependence	0.00283	0.00443	CcSEcCtD
Nafarelin—Mental disorder—Acamprosate—alcohol dependence	0.00281	0.00439	CcSEcCtD
Nafarelin—GNRHR—G alpha (q) signalling events—HTR2A—alcohol dependence	0.00281	0.0113	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—OPRM1—alcohol dependence	0.0028	0.0113	CbGpPWpGaD
Nafarelin—Malnutrition—Acamprosate—alcohol dependence	0.00279	0.00436	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—OPRK1—alcohol dependence	0.00278	0.0112	CbGpPWpGaD
Nafarelin—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.00276	0.00431	CcSEcCtD
Nafarelin—Tension—Acamprosate—alcohol dependence	0.00274	0.00428	CcSEcCtD
Nafarelin—Affect lability—Citalopram—alcohol dependence	0.00274	0.00428	CcSEcCtD
Nafarelin—Dysgeusia—Acamprosate—alcohol dependence	0.00273	0.00427	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.00272	0.011	CbGpPWpGaD
Nafarelin—Nervousness—Acamprosate—alcohol dependence	0.00271	0.00424	CcSEcCtD
Nafarelin—Alopecia—Naltrexone—alcohol dependence	0.00268	0.00419	CcSEcCtD
Nafarelin—Mental disorder—Naltrexone—alcohol dependence	0.00266	0.00416	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00266	0.0107	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00266	0.0107	CbGpPWpGaD
Nafarelin—Malnutrition—Naltrexone—alcohol dependence	0.00264	0.00413	CcSEcCtD
Nafarelin—Mood swings—Citalopram—alcohol dependence	0.00263	0.00412	CcSEcCtD
Nafarelin—Tension—Naltrexone—alcohol dependence	0.00259	0.00405	CcSEcCtD
Nafarelin—Dysgeusia—Naltrexone—alcohol dependence	0.00259	0.00404	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—NPY—alcohol dependence	0.00257	0.0104	CbGpPWpGaD
Nafarelin—Nervousness—Naltrexone—alcohol dependence	0.00257	0.00401	CcSEcCtD
Nafarelin—Dry skin—Citalopram—alcohol dependence	0.00255	0.00398	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.00251	0.0101	CbGpPWpGaD
Nafarelin—Vertigo—Acamprosate—alcohol dependence	0.00251	0.00392	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CRH—alcohol dependence	0.00248	0.01	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—HTR1B—alcohol dependence	0.00248	0.01	CbGpPWpGaD
Nafarelin—Palpitations—Acamprosate—alcohol dependence	0.00247	0.00386	CcSEcCtD
Nafarelin—Gastritis—Citalopram—alcohol dependence	0.00246	0.00384	CcSEcCtD
Nafarelin—Muscular weakness—Citalopram—alcohol dependence	0.00245	0.00383	CcSEcCtD
Nafarelin—Convulsion—Acamprosate—alcohol dependence	0.00242	0.00378	CcSEcCtD
Nafarelin—Abdominal distension—Citalopram—alcohol dependence	0.00242	0.00378	CcSEcCtD
Nafarelin—Chest pain—Acamprosate—alcohol dependence	0.00238	0.00372	CcSEcCtD
Nafarelin—Arthralgia—Acamprosate—alcohol dependence	0.00238	0.00372	CcSEcCtD
Nafarelin—Myalgia—Acamprosate—alcohol dependence	0.00238	0.00372	CcSEcCtD
Nafarelin—Sweating increased—Citalopram—alcohol dependence	0.00234	0.00366	CcSEcCtD
Nafarelin—Palpitations—Naltrexone—alcohol dependence	0.00233	0.00365	CcSEcCtD
Nafarelin—Convulsion—Naltrexone—alcohol dependence	0.00229	0.00358	CcSEcCtD
Nafarelin—Arthralgia—Naltrexone—alcohol dependence	0.00225	0.00352	CcSEcCtD
Nafarelin—Chest pain—Naltrexone—alcohol dependence	0.00225	0.00352	CcSEcCtD
Nafarelin—Myalgia—Naltrexone—alcohol dependence	0.00225	0.00352	CcSEcCtD
Nafarelin—Dysuria—Citalopram—alcohol dependence	0.00225	0.00351	CcSEcCtD
Nafarelin—Shock—Acamprosate—alcohol dependence	0.00224	0.0035	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.00224	0.00903	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Acamprosate—alcohol dependence	0.0022	0.00344	CcSEcCtD
Nafarelin—Weight increased—Citalopram—alcohol dependence	0.00219	0.00342	CcSEcCtD
Nafarelin—Weight decreased—Citalopram—alcohol dependence	0.00217	0.0034	CcSEcCtD
Nafarelin—Anorexia—Acamprosate—alcohol dependence	0.00217	0.00339	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—DRD4—alcohol dependence	0.00217	0.00877	CbGpPWpGaD
Nafarelin—Oedema—Naltrexone—alcohol dependence	0.00216	0.00337	CcSEcCtD
Nafarelin—Depression—Citalopram—alcohol dependence	0.00214	0.00334	CcSEcCtD
Nafarelin—Shock—Naltrexone—alcohol dependence	0.00212	0.00332	CcSEcCtD
Nafarelin—Acute coronary syndrome—Citalopram—alcohol dependence	0.00211	0.0033	CcSEcCtD
Nafarelin—Myocardial infarction—Citalopram—alcohol dependence	0.0021	0.00328	CcSEcCtD
Nafarelin—Hyperhidrosis—Naltrexone—alcohol dependence	0.00208	0.00326	CcSEcCtD
Nafarelin—Conjunctivitis—Citalopram—alcohol dependence	0.00208	0.00325	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00208	0.00324	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CNR1—alcohol dependence	0.00207	0.00837	CbGpPWpGaD
Nafarelin—Insomnia—Acamprosate—alcohol dependence	0.00206	0.00322	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—OPRD1—alcohol dependence	0.00205	0.0083	CbGpPWpGaD
Nafarelin—Anorexia—Naltrexone—alcohol dependence	0.00205	0.00321	CcSEcCtD
Nafarelin—Paraesthesia—Acamprosate—alcohol dependence	0.00205	0.0032	CcSEcCtD
Nafarelin—Dyspnoea—Acamprosate—alcohol dependence	0.00203	0.00318	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—DRD2—alcohol dependence	0.00202	0.00817	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—HTR7—alcohol dependence	0.00202	0.00817	CbGpPWpGaD
Nafarelin—Epistaxis—Citalopram—alcohol dependence	0.00202	0.00316	CcSEcCtD
Nafarelin—Sinusitis—Citalopram—alcohol dependence	0.00201	0.00314	CcSEcCtD
Nafarelin—Decreased appetite—Acamprosate—alcohol dependence	0.00198	0.0031	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—PDYN—alcohol dependence	0.00197	0.00796	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00196	0.00307	CcSEcCtD
Nafarelin—Insomnia—Naltrexone—alcohol dependence	0.00195	0.00305	CcSEcCtD
Nafarelin—Constipation—Acamprosate—alcohol dependence	0.00195	0.00305	CcSEcCtD
Nafarelin—Paraesthesia—Naltrexone—alcohol dependence	0.00194	0.00303	CcSEcCtD
Nafarelin—Rhinitis—Citalopram—alcohol dependence	0.00193	0.00301	CcSEcCtD
Nafarelin—Dyspnoea—Naltrexone—alcohol dependence	0.00192	0.003	CcSEcCtD
Nafarelin—Decreased appetite—Naltrexone—alcohol dependence	0.00187	0.00293	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—OPRD1—alcohol dependence	0.00187	0.00754	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.00186	0.00751	CbGpPWpGaD
Nafarelin—Constipation—Naltrexone—alcohol dependence	0.00184	0.00288	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CRHR1—alcohol dependence	0.00183	0.0074	CbGpPWpGaD
Nafarelin—Urticaria—Acamprosate—alcohol dependence	0.00181	0.00283	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—PDYN—alcohol dependence	0.00179	0.00723	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CHRM2—alcohol dependence	0.00172	0.00695	CbGpPWpGaD
Nafarelin—Urticaria—Naltrexone—alcohol dependence	0.00171	0.00268	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—AVP—alcohol dependence	0.0017	0.00688	CbGpPWpGaD
Nafarelin—Alopecia—Citalopram—alcohol dependence	0.0017	0.00266	CcSEcCtD
Nafarelin—Mental disorder—Citalopram—alcohol dependence	0.00168	0.00263	CcSEcCtD
Nafarelin—Malnutrition—Citalopram—alcohol dependence	0.00167	0.00262	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CRHR1—alcohol dependence	0.00166	0.00672	CbGpPWpGaD
Nafarelin—Tension—Citalopram—alcohol dependence	0.00164	0.00257	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—OPRK1—alcohol dependence	0.00164	0.00662	CbGpPWpGaD
Nafarelin—Dysgeusia—Citalopram—alcohol dependence	0.00164	0.00256	CcSEcCtD
Nafarelin—Asthenia—Acamprosate—alcohol dependence	0.00163	0.00256	CcSEcCtD
Nafarelin—Nervousness—Citalopram—alcohol dependence	0.00163	0.00254	CcSEcCtD
Nafarelin—Pruritus—Acamprosate—alcohol dependence	0.00161	0.00252	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—OPRM1—alcohol dependence	0.00158	0.00639	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CHRM2—alcohol dependence	0.00156	0.00632	CbGpPWpGaD
Nafarelin—Diarrhoea—Acamprosate—alcohol dependence	0.00156	0.00244	CcSEcCtD
Nafarelin—Asthenia—Naltrexone—alcohol dependence	0.00155	0.00242	CcSEcCtD
Nafarelin—Pruritus—Naltrexone—alcohol dependence	0.00153	0.00238	CcSEcCtD
Nafarelin—Dizziness—Acamprosate—alcohol dependence	0.00151	0.00236	CcSEcCtD
Nafarelin—Vertigo—Citalopram—alcohol dependence	0.0015	0.00235	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.00149	0.006	CbGpPWpGaD
Nafarelin—Palpitations—Citalopram—alcohol dependence	0.00148	0.00231	CcSEcCtD
Nafarelin—Diarrhoea—Naltrexone—alcohol dependence	0.00147	0.00231	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—NPY—alcohol dependence	0.00145	0.00588	CbGpPWpGaD
Nafarelin—Convulsion—Citalopram—alcohol dependence	0.00145	0.00227	CcSEcCtD
Nafarelin—Vomiting—Acamprosate—alcohol dependence	0.00145	0.00226	CcSEcCtD
Nafarelin—Rash—Acamprosate—alcohol dependence	0.00144	0.00225	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—OPRM1—alcohol dependence	0.00144	0.0058	CbGpPWpGaD
Nafarelin—Dermatitis—Acamprosate—alcohol dependence	0.00144	0.00224	CcSEcCtD
Nafarelin—Headache—Acamprosate—alcohol dependence	0.00143	0.00223	CcSEcCtD
Nafarelin—Dizziness—Naltrexone—alcohol dependence	0.00143	0.00223	CcSEcCtD
Nafarelin—Arthralgia—Citalopram—alcohol dependence	0.00142	0.00223	CcSEcCtD
Nafarelin—Myalgia—Citalopram—alcohol dependence	0.00142	0.00223	CcSEcCtD
Nafarelin—Chest pain—Citalopram—alcohol dependence	0.00142	0.00223	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—HTR2A—alcohol dependence	0.00142	0.00572	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HTR1B—alcohol dependence	0.0014	0.00567	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CRH—alcohol dependence	0.0014	0.00567	CbGpPWpGaD
Nafarelin—Vomiting—Naltrexone—alcohol dependence	0.00137	0.00214	CcSEcCtD
Nafarelin—Oedema—Citalopram—alcohol dependence	0.00137	0.00214	CcSEcCtD
Nafarelin—Rash—Naltrexone—alcohol dependence	0.00136	0.00212	CcSEcCtD
Nafarelin—Dermatitis—Naltrexone—alcohol dependence	0.00136	0.00212	CcSEcCtD
Nafarelin—Nausea—Acamprosate—alcohol dependence	0.00135	0.00212	CcSEcCtD
Nafarelin—Headache—Naltrexone—alcohol dependence	0.00135	0.00211	CcSEcCtD
Nafarelin—Shock—Citalopram—alcohol dependence	0.00134	0.0021	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—NPY—alcohol dependence	0.00132	0.00534	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Citalopram—alcohol dependence	0.00132	0.00206	CcSEcCtD
Nafarelin—Anorexia—Citalopram—alcohol dependence	0.0013	0.00204	CcSEcCtD
Nafarelin—Nausea—Naltrexone—alcohol dependence	0.00128	0.002	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CRH—alcohol dependence	0.00127	0.00515	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HTR1B—alcohol dependence	0.00127	0.00515	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00124	0.00195	CcSEcCtD
Nafarelin—Insomnia—Citalopram—alcohol dependence	0.00124	0.00193	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—DRD4—alcohol dependence	0.00123	0.00496	CbGpPWpGaD
Nafarelin—Paraesthesia—Citalopram—alcohol dependence	0.00123	0.00192	CcSEcCtD
Nafarelin—Dyspnoea—Citalopram—alcohol dependence	0.00122	0.0019	CcSEcCtD
Nafarelin—Decreased appetite—Citalopram—alcohol dependence	0.00119	0.00186	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CNR1—alcohol dependence	0.00117	0.00473	CbGpPWpGaD
Nafarelin—Constipation—Citalopram—alcohol dependence	0.00117	0.00183	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—DRD2—alcohol dependence	0.00114	0.00462	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HTR7—alcohol dependence	0.00114	0.00462	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—POMC—alcohol dependence	0.00113	0.00457	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—DRD4—alcohol dependence	0.00111	0.0045	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—OPRD1—alcohol dependence	0.0011	0.00445	CbGpPWpGaD
Nafarelin—Urticaria—Citalopram—alcohol dependence	0.00109	0.0017	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CNR1—alcohol dependence	0.00106	0.0043	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PDYN—alcohol dependence	0.00106	0.00427	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—DRD2—alcohol dependence	0.00104	0.00419	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HTR7—alcohol dependence	0.00104	0.00419	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CRHR1—alcohol dependence	0.000983	0.00397	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—WASF2—alcohol dependence	0.000983	0.00397	CbGpPWpGaD
Nafarelin—Asthenia—Citalopram—alcohol dependence	0.00098	0.00153	CcSEcCtD
Nafarelin—Pruritus—Citalopram—alcohol dependence	0.000966	0.00151	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—AVP—alcohol dependence	0.000962	0.00389	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—WASF1—alcohol dependence	0.000942	0.0038	CbGpPWpGaD
Nafarelin—Diarrhoea—Citalopram—alcohol dependence	0.000935	0.00146	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CHRM2—alcohol dependence	0.000924	0.00373	CbGpPWpGaD
Nafarelin—Dizziness—Citalopram—alcohol dependence	0.000903	0.00141	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—AVP—alcohol dependence	0.000874	0.00353	CbGpPWpGaD
Nafarelin—Vomiting—Citalopram—alcohol dependence	0.000868	0.00136	CcSEcCtD
Nafarelin—Rash—Citalopram—alcohol dependence	0.000861	0.00135	CcSEcCtD
Nafarelin—Dermatitis—Citalopram—alcohol dependence	0.00086	0.00134	CcSEcCtD
Nafarelin—Headache—Citalopram—alcohol dependence	0.000856	0.00134	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—OPRM1—alcohol dependence	0.000848	0.00343	CbGpPWpGaD
Nafarelin—Nausea—Citalopram—alcohol dependence	0.000811	0.00127	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—HTR2A—alcohol dependence	0.000801	0.00323	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPY—alcohol dependence	0.000781	0.00315	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR1B—alcohol dependence	0.000753	0.00304	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CRH—alcohol dependence	0.000753	0.00304	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HTR2A—alcohol dependence	0.000727	0.00294	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—DRD4—alcohol dependence	0.000658	0.00266	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—POMC—alcohol dependence	0.000639	0.00258	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CNR1—alcohol dependence	0.000628	0.00254	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR7—alcohol dependence	0.000613	0.00248	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—DRD2—alcohol dependence	0.000613	0.00248	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—POMC—alcohol dependence	0.000581	0.00234	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AVP—alcohol dependence	0.000516	0.00208	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR2A—alcohol dependence	0.000429	0.00173	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—POMC—alcohol dependence	0.000343	0.00139	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EP300—alcohol dependence	0.000228	0.000919	CbGpPWpGaD
